Connection

Yusuf Hannun to Brain

This is a "connection" page, showing publications Yusuf Hannun has written about Brain.
Connection Strength

0.919
  1. Substrate specificity of rat brain ceramidase. J Lipid Res. 2002 Jan; 43(1):141-8.
    View in: PubMed
    Score: 0.091
  2. Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. J Biol Chem. 2001 May 18; 276(20):16758-66.
    View in: PubMed
    Score: 0.086
  3. Purification of rat brain membrane neutral sphingomyelinase. Methods Enzymol. 2000; 311:156-64.
    View in: PubMed
    Score: 0.079
  4. Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain. J Biol Chem. 1999 Sep 24; 274(39):27948-55.
    View in: PubMed
    Score: 0.078
  5. Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. J Biol Chem. 1998 Dec 18; 273(51):34472-9.
    View in: PubMed
    Score: 0.074
  6. Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain. PLoS Genet. 2015 Oct; 11(10):e1005591.
    View in: PubMed
    Score: 0.059
  7. Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury. J Biol Chem. 2014 May 09; 289(19):13142-54.
    View in: PubMed
    Score: 0.053
  8. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain. Hum Gene Ther. 2012 Aug; 23(8):891-902.
    View in: PubMed
    Score: 0.048
  9. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol. 1992 Apr; 117(1):121-33.
    View in: PubMed
    Score: 0.046
  10. Purification and characterization of a second type of neutral ceramidase from rat brain: a second more hydrophobic form of rat brain ceramidase. Biochim Biophys Acta. 2011 Apr; 1811(4):242-52.
    View in: PubMed
    Score: 0.043
  11. Rat brain protein kinase C. Kinetic analysis of substrate dependence, allosteric regulation, and autophosphorylation. J Biol Chem. 1990 Feb 15; 265(5):2962-72.
    View in: PubMed
    Score: 0.040
  12. Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J Biol Chem. 1985 Aug 25; 260(18):10039-43.
    View in: PubMed
    Score: 0.029
  13. Mass spectrometric analysis of ceramide perturbations in brain and fibroblasts of mice and human patients with peroxisomal disorders. Rapid Commun Mass Spectrom. 2004; 18(14):1569-74.
    View in: PubMed
    Score: 0.026
  14. Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem. 2000 Jul 14; 275(28):21508-13.
    View in: PubMed
    Score: 0.021
  15. Analysis of ceramide-activated protein phosphatases. Methods Enzymol. 2000; 312:420-8.
    View in: PubMed
    Score: 0.020
  16. Purification and characterization of ceramide-activated protein phosphatases. Biochemistry. 1998 Aug 11; 37(32):11232-8.
    View in: PubMed
    Score: 0.018
  17. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem. 1993 Jul 25; 268(21):15523-30.
    View in: PubMed
    Score: 0.013
  18. Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv Lipid Res. 1993; 25:91-104.
    View in: PubMed
    Score: 0.012
  19. Cloning and characterization of the major promoter of the human protein kinase C beta gene. Regulation by phorbol esters. J Biol Chem. 1992 Oct 15; 267(29):20804-10.
    View in: PubMed
    Score: 0.012
  20. Selective changes in protein kinase C isoenzymes in rat liver nuclei during liver regeneration. Biochem Biophys Res Commun. 1992 Feb 14; 182(3):1333-9.
    View in: PubMed
    Score: 0.012
  21. Activation of casein kinase II by sphingosine. J Biol Chem. 1991 Nov 15; 266(32):21773-6.
    View in: PubMed
    Score: 0.011
  22. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. Hum Mol Genet. 2010 Mar 15; 19(6):1088-97.
    View in: PubMed
    Score: 0.010
  23. The adriamycin-iron(III) complex is a potent inhibitor of protein kinase C. J Biol Chem. 1989 Jun 15; 264(17):9960-6.
    View in: PubMed
    Score: 0.010
  24. Mixed micelle assay of protein kinase C. Methods Enzymol. 1986; 124:353-9.
    View in: PubMed
    Score: 0.008
  25. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest. 2003 Oct; 112(7):1080-94.
    View in: PubMed
    Score: 0.006
  26. Phorbol myristate acetate-dependent association of protein kinase C alpha with phospholipase D1 in intact cells. Biochim Biophys Acta. 1997 Aug 16; 1347(2-3):199-204.
    View in: PubMed
    Score: 0.004
  27. Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics. 1997 Feb; 28(1):37-41.
    View in: PubMed
    Score: 0.004
  28. 12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. Proc Natl Acad Sci U S A. 1995 Sep 26; 92(20):9323-7.
    View in: PubMed
    Score: 0.004
  29. Specificity and mechanism of protein kinase C activation by sn-1,2-diacylglycerols. Proc Natl Acad Sci U S A. 1986 Mar; 83(5):1184-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.